Join the members group    Follow Us

Expert Groups

New Expert Groups

We hope to establish an up to date database of members who have expert knowledge within these key areas, and establish one lead/chairperson for each Expert Group who would facilitate and collate the responses from individual members of the groups. The chairs of each Expert Group would work closely with members of the PCG to finalise responses in a timely and efficient manner.

  1. Governmental and Healthcare Policy relevant to Pharmaceutical Medicine (incl. drug safety and regulatory)
  2. Orphan Disease/Gene Therapy/ Innovative technologies
  3. Clinical Development (processes/policy)
  4. Pharmaceutical development in Paediatrics and other vulnerable populations
  5. Important/Key therapeutic areas (for Pharmaceutical Medicine) Neurological disorders/ Neuropsychiatric/ HIV/ Vaccines/ cardiovascular)
  6. Oncology


Responsibilities of group members
It is difficult to precisely stipulate the time requirement for involvement in each group. It is likely that each group will be required to prepare comment on between 2-4 consultations per year and give comments on 1-2 press releases, though comment will not be expected from each member of the group on every occasion. The Expert Groups will not meet in person, but conference calls may be arranged occasionally to discuss submissions. Responses to consultations and press releases will represent the official FPM position on a wide range of important topics which will/may be made public through the media. Therefore, it is important that members who are interested in contributing are:

  • Comfortable that their level of expert knowledge is such that their input could be considered the official Faculty position (subject to review from the chairperson and PCG) and made available in the press
  • Committed to responding to requests for input from the PCG on a relatively frequent basis and in a timely manner, owing often to short deadlines.

* * * Call for members now closed * * *